ASCO 2025 – Day 1 Breast Cancer Highlights with Drs. Jamil Asselah and Kim Ma

Drs. Jamil Asselah and Kim Ma recap Day 1 of ASCO 2025, where the focus was strongest on hormone receptor–positive breast cancer, highlighting updated INAVO120 survival data and what’s ahead for Day 2.